MIRA Pharmaceuticals Inc.
1.15
-0.02 (-1.71%)
At close: Jan 15, 2025, 12:15 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20
Revenue n/a n/a n/a n/a
Cost of Revenue 8.53M n/a n/a n/a
Gross Profit -8.53M n/a n/a n/a
Operating Income -8.53M -7.05M -2.15M -67.63K
Interest Income n/a n/a n/a n/a
Pretax Income -11.98M -7.06M -2.18M -67.99K
Net Income -11.98M -7.06M -2.18M -67.99K
Selling & General & Admin 6.95M 2.99M 770.12K 52.98K
Research & Development 1.57M 2.35M 684.45K 14.65K
Other Expenses 0.00 -1.70M -697.60K n/a
Operating Expenses 8.53M 7.05M 2.15M 67.63K
Interest Expense 3.46M 10.25K 24.37K 364.00
Selling & Marketing Expenses 453.55K n/a n/a 52.82K
Cost & Expenses 8.53M 7.05M 2.15M 67.63K
Income Tax n/a -7.05K -2.15K -202.89
Shares Outstanding (Basic) 18.57M 14.75M 14.75M 14.75M
Shares Outstanding (Diluted) 18.57M 14.75M 14.75M 14.75M
EPS (Basic) -0.65 -0.48 -0.15 -0.00
EPS (Diluted) -0.65 -0.48 -0.15 -0.00
EBITDA n/a -7.05M -2.15M n/a
Depreciation & Amortization 8.53M 7.05M 2.15M 202.89K